{
  "prompt": {
    "guidelineId": "cg1127-neonatal-abstinence-scoring-pdf",
    "fieldsProcessed": [
      "humanFriendlyName",
      "organisation",
      "yearProduced",
      "summary"
    ],
    "enhancedFields": 4,
    "contentLength": 6543
  },
  "response": "{\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"Neonatal Abstinence Syndrome Assessment and Management\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"The text does not explicitly mention the publishing organization or institution. However, based on the content and style, it is likely from a **NHS Trust** or similar healthcare institution, but no specific acronym like NICE, WHO, or RCOG is stated. Since the guideline references \\\"Trust and National recommendations,\\\" the closest inferred organization is: **NHS**\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"There is no publication year mentioned in the provided text. If you have another guideline text with a visible publication year, please share it, and I'll extract the year for you\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Neonatal Abstinence Syndrome (NAS) Guideline** **Scope**: Applies to pediatric, neonatal, and midwifery staff caring for newborns at risk of NAS due to maternal substance use. **Key Recommendations**: - **Assessment**: Monitor for withdrawal symptoms using scoring tools. - **Antenatal Care**: Provide education, neonatal unit visits if needed, Hepatitis B vaccination, and social services referral. - **Perinatal Care**: Avoid Pethidine/Diamorphine in opiate-dependent mothers; do not give Naloxone. - **Postnatal Care**: Keep mother and baby together; observe for withdrawal; initiate scoring and pharmacological treatment if needed. - **Pharmacological Treatment**: - **Opiate withdrawal**: Start morphine (125 mcg/kg/day, 4x daily), wean based on NAS scores. - **Non-opiate withdrawal**: Phenobarbitone for alcohol, chlorpromazine for benzodiazepines. - **Discharge Criteria**: Stable NAS scores, normal feeding/sleeping, no morphine dose changes for 36 hours. - **Follow-up**: Ensure discharge planning, social support, and medication weaning schedule. **Additional Measures**: - Hepatitis B vaccine/immunoglobulin for high-risk infants. - Avoid breastfeeding if contraindicated by maternal medication. - Provide parental education and support. **Audit**: Monitor antenatal tasks, NAS scoring, and discharge planning compliance\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "endpoint": "enhanceGuidelineMetadata",
  "timestamp": "2025-06-18T21-48-34",
  "textContent": "AI: DeepSeek (deepseek-chat)\n\nQ: {\n  \"guidelineId\": \"cg1127-neonatal-abstinence-scoring-pdf\",\n  \"fieldsProcessed\": [\n    \"humanFriendlyName\",\n    \"organisation\",\n    \"yearProduced\",\n    \"summary\"\n  ],\n  \"enhancedFields\": 4,\n  \"contentLength\": 6543\n}\n\nA: {\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"Neonatal Abstinence Syndrome Assessment and Management\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"The text does not explicitly mention the publishing organization or institution. However, based on the content and style, it is likely from a **NHS Trust** or similar healthcare institution, but no specific acronym like NICE, WHO, or RCOG is stated. Since the guideline references \\\"Trust and National recommendations,\\\" the closest inferred organization is: **NHS**\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"There is no publication year mentioned in the provided text. If you have another guideline text with a visible publication year, please share it, and I'll extract the year for you\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Neonatal Abstinence Syndrome (NAS) Guideline** **Scope**: Applies to pediatric, neonatal, and midwifery staff caring for newborns at risk of NAS due to maternal substance use. **Key Recommendations**: - **Assessment**: Monitor for withdrawal symptoms using scoring tools. - **Antenatal Care**: Provide education, neonatal unit visits if needed, Hepatitis B vaccination, and social services referral. - **Perinatal Care**: Avoid Pethidine/Diamorphine in opiate-dependent mothers; do not give Naloxone. - **Postnatal Care**: Keep mother and baby together; observe for withdrawal; initiate scoring and pharmacological treatment if needed. - **Pharmacological Treatment**: - **Opiate withdrawal**: Start morphine (125 mcg/kg/day, 4x daily), wean based on NAS scores. - **Non-opiate withdrawal**: Phenobarbitone for alcohol, chlorpromazine for benzodiazepines. - **Discharge Criteria**: Stable NAS scores, normal feeding/sleeping, no morphine dose changes for 36 hours. - **Follow-up**: Ensure discharge planning, social support, and medication weaning schedule. **Additional Measures**: - Hepatitis B vaccine/immunoglobulin for high-risk infants. - Avoid breastfeeding if contraindicated by maternal medication. - Provide parental education and support. **Audit**: Monitor antenatal tasks, NAS scoring, and discharge planning compliance\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "ai_provider": "DeepSeek",
  "ai_model": "deepseek-chat",
  "token_usage": null
}